Craft

DSM

Revenue

€7.6 B

FY, 2023

DSM Summary

Company Summary

Overview
DSM (also known as Royal DSM, formerly known as Koninklijke DSM) is a company that specializes in solutions for human and animal health and nutrition. It offers feed additives, vitamins, carotenoids, eubiotics, feed enzymes, nutrition improvement solutions, aroma ingredients, natural bio-actives, peptides and polymers, and other products. The company serves animal feed, dietary supplements, early life nutrition, food and beverage, personal care, and pharma solutions markets. DSM merged with Firmenich to form DSM-Firmenich.
Type
Subsidiary
Status
Active
Founded
1902
HQ
Heerlen, NL | view all locations
Website
https://www.dsm.com/corporate/home.html
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Thomas Leysen

    Thomas Leysen, Chair of the Supervisory Board

    • John Ramsay

      John Ramsay, Deputy Chair of the Supervisory Board

    • Corien M. Wortmann-Kool

      Corien M. Wortmann-Kool, Supervisory Board Member

      Operating MetricsView all

      Patent Applications Filed Yearly

      397
      40.8%

      FY, 2018

      Suppliers

      35K
      2.9%

      FY, 2018

      Countries (Facilities)

      40

      FY, 2018

      LocationsView all

      232 locations detected

      • Heerlen, Limburg HQ

        Netherlands

        1 Het Overloon

      • Ames, IA

        United States

        616 Dayton Ave

      • Arcadia, WI

        United States

        501 S Washington St

      • Belvidere, NJ

        United States

        200 Roche Dr

      • Berkeley, CA

        United States

        2840 Seventh St

      • Boulder, CO

        United States

        4909 Nautilus Ct. N Suite 230

      and 226 others

      DSM Financials

      Summary Financials

      Revenue (FY, 2023)
      €7.6B
      Gross profit (FY, 2023)
      €1.6B
      Net income (FY, 2023)
      €2.3B
      Cash (FY, 2023)
      €2.2B
      EBIT (FY, 2023)
      (€412.0M)

      Footer menu